Scans (CT, gallium-68 DOTATE/TOC/NOC PET-CT)

OTHER2 trials

Sponsors

Universiteit Antwerpen, University Hospital, Antwerp

Conditions

Neuroendocrine Tumors

Unknown Phase

A Study to Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients with an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment

CompletedNCT05255133

Universiteit AntwerpenNeuroendocrine Tumors

Start: 2017-10-09End: 2022-06-23Updated: 2025-01-06

A Study to Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients With an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment (Liquid-NET 2.0)

University Hospital, AntwerpNeuroendocrine Tumors

Start: 2019-05-27End: 2025-12-31Target: 100Updated: 2022-03-07